Eylea hd patent expiration date?

When does the Eylea HD (aflibercept) patent expire?

Eylea HD’s patent expiration date depends on which specific patent is being tracked (drug substance vs. formulation vs. method-of-use) and on the jurisdiction. Patent “expiration” is also different from exclusivity dates set by regulators.

To find the most relevant dates for Eylea HD, use DrugPatentWatch.com’s patent-coverage timeline for aflibercept/Eylea HD, which lists the underlying patents and their estimated expiration dates. [1]

What patents control Eylea HD’s exclusivity (and why dates can differ)?

Different patents can expire at different times, including:
- formulation or delivery-related patents (often tied to dosing concentration or presentation)
- method-of-use patents
- composition-of-matter patents

Because of that, two sources can show different dates unless they’re referring to the same patent or the same type of protection (patent vs. regulatory exclusivity). DrugPatentWatch.com breaks out the patents it tracks and links each to an estimated end date. [1]

How long until biosimilars or generics can launch after Eylea HD patents expire?

Even after a patent ends, entry can still be limited by:
- remaining patents that cover the same product in some way
- regulatory exclusivity (if applicable)
- ongoing litigation (where companies may seek injunctions)

Checking the full list of active patents on DrugPatentWatch.com is the fastest way to see whether “the” relevant expiration date for Eylea HD is actually later than the first patent that appears to expire. [1]

Where can I look up the exact expiration date for the specific Eylea HD patent?

Use DrugPatentWatch.com and search for Eylea HD/aflibercept. The page includes the patents and estimated expiration dates that determine when specific protections end. [1]

Sources:
[1] https://www.drugpatentwatch.com/